Effects of amisulpride on human resting cerebral perfusion. (Q46667464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

title

Effects of amisulpride on human resting cerebral perfusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Heiko Graf

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

Maike Wiegers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

Birgit Abler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

publication date

13 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

number of pages

9

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

volume

229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

95-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Neural correlates of erotic stimulation under different levels of female sexual hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Reconsidering GHB: orphan drug or new model antidepressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Behavioral analyses of GHB: receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Quantification of Cerebral Blood Flow as Biomarker of Drug Effect: Arterial Spin Labeling phMRI After a Single Dose of Oral Citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Unravelling the brain targets of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The role of dopamine in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The 5-HT7 receptor and disorders of the nervous system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Nonparametric analysis of statistic images from functional mapping experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Cortical responses to amphetamine exposure studied by pCASL MRI and pharmacokinetic/pharmacodynamic dose modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

The pharmacology of sulpiride--a dopamine receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Consensus on the use of substituted benzamides in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects of large-scale nonstationarity on parametric maps. A study of rest perfusion CASL data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Components of acquisition-to-acquisition variance in continuous arterial spin labelling (CASL) imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Components of variance in brain perfusion and the design of studies of individual differences: the baseline study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Magnetic resonance imaging of perfusion using spin inversion of arterial water

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

21 January 2018

12 December 2020

Amisulpride: a review of its use in the management of schizophrenia

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3091-Z

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

21 January 2018

1 reference

12 December 2020

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.

1 reference

12 December 2020

Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.

1 reference

12 December 2020

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

1 reference

12 December 2020

gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.

1 reference

12 December 2020

Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders

1 reference

12 December 2020

Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 reference

12 December 2020

10.1007/S00213-013-3091-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23584671 AND SRC:MED&resulttype=core&format=json

28 February 2020

1 reference